The Swiss drug agency, Swissmedic, approved on Friday the immunization against COVID-19 of children from the age of five with Pfizer-Biontech’s messenger RNA vaccine, Comirnaty.
“Results of clinical trials show that vaccination is safe and effective” among children 5 to 11 years, which until now could not be vaccinated, according to Swissmedic.
Comirnaty is administered in two 10-microgram doses three weeks apart, “which corresponds to one-third of the dose administered to adolescents and adults,” Swissmedic emphasizes.
A clinical trial “still ongoing with more than 1,500 participants shows that this COVID-19 vaccine almost completely prevents serious diseases caused by the SARS-CoV-2 virus in children aged 5 to 11 years“The Swiss agency reported. Until now, only children over 12 years of age could be vaccinated.
By giving the green light to vaccinate children from the age of 5, Switzerland joins Portugal, Italy, Greece and Spain.
Canada and the United States, as well as Israel and Chile, also authorized the vaccination of children from this age.